Inhibitors targeting two-component signal transduction

Advances in Experimental Medicine and Biology

Volumn 631, Issue , 2008, Pages 229-236

  Watanabe, Takafumi ^a   Okada, Ario ^a   Gotoh, Yasuhiro ^a   Utsumi, Ryutaro ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 [4 (2 TRITYLETHOXY)PHENYL]ETHYL]GUANIDINE; ANTIINFECTIVE AGENT; ARANOROSINOL B; BENZIMIDAZOLE; BIPHENYLDIOL; CLOSANTEL; CYCLOHEXENE DERIVATIVE; IMIDAZOLE DERIVATIVE; ISOTHIAZOLE DERIVATIVE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN HISTIDINE KINASE; PROTEIN HISTIDINE KINASE INHIBITOR; STREPTOPYRROLE; THIENOPYRIDINE DERIVATIVE; TRITYL DERIVATIVE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN-HISTIDINE KINASE; YYCF PROTEIN, BACTERIA;

ANTIBACTERIAL ACTIVITY; AUTOPHOSPHORYLATION; BACILLUS SUBTILIS; BACTERIAL GROWTH; CELL GROWTH; DRUG STRUCTURE; GENE STRUCTURE; GENOME SIZE; IC 50; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM; COMPUTER INTERFACE; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; GENETICS; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PHYSIOLOGY; BACTERIAL PROTEINS; DRUG DESIGN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; SIGNAL TRANSDUCTION; USER-COMPUTER INTERFACE;

EID: 55949126211     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78885-2_16     Document Type: Review

References (36)

1. Inouye M, Dutra R, eds. Histidine kinases in signal transduction: San Diego: Academic Press. 2003.
2. Parkinson JS. Kofoid EC. Communication module in bacterial signaling proteins. Annu Rev Genet 1992; 26:71-121.
3. T Deretic V. An essential two-component signal transduction system in Mycobacterium tuberculosis. J Bacteriol 2000; 182:3832-3838.
4. Beir D. Frank R. Molecular characterization oftwo-component systemsof Helicobacter pylori. J Bacteriol 2000; 182:2068-2076.
5. Fabret C, Hoch JA. A two-component signal transduction system essential for growth of Bacillussubtilis: implications for anti-infective therapy. J Bacteriol 1998; 180:6375-6383.
6. Hancock L. Perego M. Two-component signal transduction in Enterococcus faecalis. J Bacteriol2002; 184:5819-5825.
7. Lange R, Wagner C, de Saizieu A et al. Domain organization and molecular characterization of 13 two-component systems identified by genome sequencing of Streptococcus pneumoniae. Gene 1999; 237:223-234.
8. Throup JP. Korerke KK, Bryant AP et al. A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol Microbiol 2000; 35:566-576.
9. Martin PK, Li T, Sun D et al. Role in cell permeability of an essential two-component system in Staphylococcus aureus. J Bacreriol 1999; 181:3666-3673.
10. Macielag MJ, Goldschmidt R. Inhibitors of bacterial two-component signaling systems.Exp Opin Invest Drugs 2000; 9:2351-2369.
11. Matsushita M, Janda KD. Histidine kinases as targets for new antimicrobial agents. Bioorg Med Chern 2002; 10:855-867.
12. BarretteJF, HochJA. Two-component signal transduction as a target for microbial anti-infective therapy. Antimicrob Agents Chemother 1998; 42:1529-1536.
13. Roychoudhurry S, Zielinski NA, Ninfa AJ et aI. Inhibitor oftwo-component signal transduction systems: Inhibition of alginate gene activation in Pseudomonaas aeruginosa. Proc Nat! Acad Sci USA 1993; 90:965-969.
14. Yamamoto K, Kitayama T, Ishida N et al. Identification and characterization of a potent antibacterial agent, NH125 against drug-resistant bacteria. Biosci Biotechnol Biochem 2000; 64:912-923.
15. Gilmour R, Foster JE, Sheng Q et aI. New class of competitive inhibitor of bacterial histidine kinases. J Bacteriol 2005; 187:8196-8200.
16. Hilliard JJ, Goldschmidt RM, Licata L et aI. Multiple mechanisms of Action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob Agents Chemother 1999; 43:1693-1699.
17. Barrett JF, Goldschmidt RM, Lawrence LE et al. Antibacterial agents that inhibit two-component signal transduction systems. Proc Nat! Acad Sci USA 1998; 95:5317-5322.
18. Trew SJ, Wrigley SK, Pairet L et aI. Novel Streptopyrroles from Streptomyces rimousus with bacterial protein histidine kinase inhibitory and antimicrobial activities. J Antibiotics 2000; 53:1-11.
19. Yamamoto K, Kitayama T, Minagawa S et aI. Antibacterial agents that inhibit histidine protein kinase YycG of Bacillus subtilis. Biosci Biotechnol Biochem 2001; 65:2306-2310.
20. Kitayama T, Iwabuchi R, Minagawa S et aI. Unprecedented olefin-dependent histidine-kinase inhibitory of zerumbone ring-opening material. Bioorgn Medicin Chern. Lett 2004; 14:5943-5946.
21. Okada A, Gotch Y, Watanabe T et al. Targeting two-component signal transduction:a novel drug discovery system. Methods Enzymol2007; 422:386-395.
22. Watanabe T, Hashimoto Y,YamamotoK et aI. Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus. J Antibiot 2003; 56:1045-1052.
23. Kamogashira T, Takegata S. A screening method for cell wall inhibitors using a D-cycloserine hypersensitive mutant. J Antibiot 1988; 41:803-806.
24. Numara K, Yamamoto H, Hatori M et aI. Isolation of an aminoglycoside hypersensitive mutant and its application in screening. J Antibiot 1986; 39:994-1000.
25. Furuta E, Yamamoto K, Tatebe D et aI. Targeting protein homodimerization: A novel drug discovery system. FEBS Lett 2005; 579:2065-2070.
26. Hidaka Y, Park H, Inouye M. Demonstration of dimer formation of the cytoplasmic domain of a transmembrane osmosensor protein, EnvZ of Escherichia coli using Nvhistidine tag affinity chromatography. FEBS Lett 1997; 400:238-243.
27. Tomomori C, Tanaka T, Dutra R er al. Solution structure of the homodimerization core domain of Escherichia coli histidine kinase EnvZ. Nat Struc Bioi 1999; 6:729-734.
28. Watanabe T, Hashimoto Y, Umemoto Y et al. Molecular characterization of the essential response regulator protein YycF in Bacillus subtilis. J Mol Microbiol Biorechnol 2003; 6:155-163.
29. Qin Z, Zhang J, XU B er al. Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections. BMC Microbiol2006; 6:1-18.
30. Qin Z, Lee B, ZhangJ et aI. Antimicrobial activities ofYycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms, FEMS Microbiol Lett in press.
31. Nierman WC, Feldblyum TV, Laub MT et al. Complete genome sequence of Caulobacter crescentus. Proc Nat! Acad Sci USA 2001; 98:4136-4141.
32. Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393:537-544.
33. TombJF, White 0, Ket!avage AR et at. The complete genomesequenceof the gastricpathogen Helicobacter pylori. Nature 2000; 388:539-547.
34. Kunst F, Ogasawara N, Moszer I et aI. The complete genome sequence of the gram-positive bacterium Bacillus subtilis, Nature 1997; 390:249-256.
35. Hoskins J, Alborn WE Jr, Arnold J et al. Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol 2001; 183:5709-5717.
36. Kuroda M, Ohta T, Uchiyama I et al. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 2001; 357:1225-1240.